JPWO2023219072A5 - - Google Patents
Info
- Publication number
- JPWO2023219072A5 JPWO2023219072A5 JP2024520453A JP2024520453A JPWO2023219072A5 JP WO2023219072 A5 JPWO2023219072 A5 JP WO2023219072A5 JP 2024520453 A JP2024520453 A JP 2024520453A JP 2024520453 A JP2024520453 A JP 2024520453A JP WO2023219072 A5 JPWO2023219072 A5 JP WO2023219072A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- cancer
- seq
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022077725 | 2022-05-10 | ||
| PCT/JP2023/017369 WO2023219072A1 (ja) | 2022-05-10 | 2023-05-09 | 抗体－薬物コンジュゲートと抗ＳＩＲＰα抗体の組み合わせ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023219072A1 JPWO2023219072A1 (enExample) | 2023-11-16 |
| JPWO2023219072A5 true JPWO2023219072A5 (enExample) | 2026-05-13 |
Family
ID=88730555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024520453A Pending JPWO2023219072A1 (enExample) | 2022-05-10 | 2023-05-09 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250282865A1 (enExample) |
| EP (1) | EP4523702A4 (enExample) |
| JP (1) | JPWO2023219072A1 (enExample) |
| KR (1) | KR20250008738A (enExample) |
| CN (1) | CN119136832A (enExample) |
| TW (1) | TW202408584A (enExample) |
| WO (1) | WO2023219072A1 (enExample) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| US5885573A (en) | 1993-06-01 | 1999-03-23 | Arch Development Corporation | Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| AU691811B2 (en) | 1993-06-16 | 1998-05-28 | Celltech Therapeutics Limited | Antibodies |
| EP3493845A4 (en) | 2016-08-03 | 2020-04-15 | The Board of Trustees of the Leland Stanford Junior University | INTERRUPTION OF FC RECEPTOR USE ON MACROPHAGES TO IMPROVE THE EFFECTIVENESS OF ANTI-SIRPALPHA ANTIBODY THERAPY |
| JPWO2018110515A1 (ja) * | 2016-12-12 | 2019-10-24 | 第一三共株式会社 | 抗体−薬物コンジュゲートと免疫チェックポイント阻害剤の組み合わせ |
| PT3443010T (pt) | 2017-02-17 | 2024-10-21 | Ose Immunotherapeutics | Novos anticorpos anti-sirpa e suas aplicações terapêuticas |
| JP7160833B2 (ja) | 2017-04-13 | 2022-10-25 | サイロパ ビー．ブイ． | 抗ｓｉｒｐアルファ抗体 |
| MX2020013068A (es) * | 2018-07-10 | 2021-03-02 | Univ Kobe Nat Univ Corp | Anticuerpo anti proteína reguladora de señales alfa sirpalfana. |
| PE20210642A1 (es) * | 2018-07-13 | 2021-03-23 | Gilead Sciences Inc | Inhibidores de pd-1/pd-l1 |
| CN113412279B (zh) * | 2018-11-15 | 2024-09-24 | 拜奥迪斯私人有限公司 | 人源化抗SIRPα抗体 |
| US20230414778A1 (en) * | 2020-11-11 | 2023-12-28 | Daiichi Sankyo Company, Limited | COMBINATION OF ANTIBODY-DRUG CONJUGATE WITH ANTI-SIRPalpha ANTIBODY |
-
2023
- 2023-05-09 TW TW112117155A patent/TW202408584A/zh unknown
- 2023-05-09 EP EP23803549.7A patent/EP4523702A4/en active Pending
- 2023-05-09 CN CN202380037780.4A patent/CN119136832A/zh active Pending
- 2023-05-09 WO PCT/JP2023/017369 patent/WO2023219072A1/ja not_active Ceased
- 2023-05-09 JP JP2024520453A patent/JPWO2023219072A1/ja active Pending
- 2023-05-09 US US18/862,729 patent/US20250282865A1/en active Pending
- 2023-05-09 KR KR1020247035385A patent/KR20250008738A/ko active Pending